Levetiracetam Sanovel

Levetiracetam, the active ingredient in Levetiracetam Sanovel, is an anticonvulsant (pyrrolidine derivative) presented as an oral tablet for oral use. It is prescribed to manage partial‑onset, generalized tonic‑clonic, and myoclonic seizures in patients with epilepsy, and is marketed throughout the European Union in compliance with EU pharmaceutical standards.

GNH USA supplies Levetiracetam Sanovel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory documentation and logistics support for global procurement, and ensuring timely delivery.

Levetiracetam is an antiepileptic drug used to control various seizure types by reducing neuronal hyper‑excitability. - Partial‑onset seizures: reduces frequency and severity of focal seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes. - Myoclonic seizures: diminishes rapid, involuntary muscle jerks.

Levetiracetam may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired. - Somnolence: increased sleepiness. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Severe allergic reactions (e.g., Stevens‑Johnson syndrome): skin rash and mucosal involvement. - Mood changes including depression or suicidal thoughts: monitor mental health. - Aggression or hostility: behavioral alterations requiring evaluation.

When prescribing levetiracetam, clinicians should consider several safety aspects. - Renal function: dose may need adjustment in patients with impaired renal clearance. - Pregnancy: safety not established; use only if benefit outweighs risk. - Psychiatric history: monitor for mood changes or aggression. - Concomitant CNS depressants: may increase sedation. - Store at ambient temperature: keep in original container, protect from moisture and light.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: may decrease levetiracetam efficacy. - Phenytoin: may lower exposure to levetiracetam.

Moderate Interactions (Monitor Closely): - Alcohol: additive central nervous system depression. - Other antiepileptics (e.g., valproate): monitor seizure control. - Oral contraceptives: levetiracetam may reduce hormonal efficacy.